{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:52:20Z","timestamp":1781941940170,"version":"3.54.5"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is an urgent need for influenza vaccine strategies that enhance protection  against influenza virus drift and across different subtypes. The conserved viral nucleoprotein (NP) is the most abundant viral protein during replication, and a target for broadly protective cellular immune responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Guided by annual WHO-recommended seasonal vaccine strains, we engineered synthetic DNA vaccine candidates encoding vaccine-aligned common consensus (VACC) immunogens designed to represent the immune diversity of seasonal H1N1 and H3N2 virus NP proteins (pVACC-NPH1; pVACC-NPH3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both pVACC-NPH1 and pVACC-NPH3 DNA vaccines induced robust cellular immune responses in mice, including the induction of durable responses. Immunization with a single dose of either DNA vaccine 14 days prior to lethal A\/California\/2009 H1N1 virus challenge provided protection against mortality. Single dose co-administration of pVACC-NPH3 with an HA-expressing DNA vaccine (pHAH1) and plasmid-encoded adjuvant pIL-12 afforded improved protection against morbidity and mortality in a high-dose challenge model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These data highlight the potential of heterologous cellular immunity induced by engineered NP immunogens to complement HA-based approaches to significantly improve challenge outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1632121","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:31:53Z","timestamp":1764138713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunization"],"prefix":"10.3389","volume":"16","author":[{"given":"Ebony N.","family":"Gary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail R.","family":"Trachtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Tursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tomirotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline D.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Custodio","family":"Zegarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey E.","family":"Hojecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micki","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayamanna","family":"Wickramasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"B2","article-title":"Influenza (seasonal) - Fact Sheet","year":""},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012220360-2\/50015-5","article-title":"Antigenic variation in influenza viruses","volume-title":"Origin and evolution of viruses","author":"Webster","year":"1999"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: the challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-015-4899-z","article-title":"Antigenic variation of the human influenza A (H3N2) virus during the 2014\u20132015 winter season","volume":"58","author":"Hua","year":"2015","journal-title":"Sci China Life Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41598-020-80895-w","article-title":"Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017\u20132020","volume":"11","author":"Suntronwong","year":"2021","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"105785","DOI":"10.1016\/j.antiviral.2023.105785","article-title":"Broadly neutralizing antibodies to combat influenza virus infection","volume":"221","author":"Sun","year":"2024","journal-title":"Antiviral Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.immuni.2025.02.025","article-title":"Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins","volume":"58","author":"Guthmiller","year":"2025","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.102","article-title":"A synthetic micro-consensus DNA vaccine generates comprehensive influenza A H3N2 immunity and protects mice against lethal challenge by multiple H3N2 viruses","volume":"29","author":"Elliott","year":"2018","journal-title":"Hum Gene Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s42003-023-04793-3","article-title":"Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine","volume":"6","author":"Dzimianski","year":"2023","journal-title":"Commun Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070793","article-title":"Next generation of computationally optimized broadly reactive HA vaccines elicited cross-reactive immune responses and provided protection against H1N1 virus infection","volume":"9","author":"Huang","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10586","DOI":"10.1038\/s41598-025-95479-9","article-title":"Design and evaluation of a poly-epitope based vaccine for the induction of influenza A virus cross-reactive CD8 + T cell responses","volume":"15","author":"Dam","year":"2025","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000085","article-title":"Cellular proteins in influenza virus particles","volume":"4","author":"Shaw","year":"2008","journal-title":"PLoS pathogens"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2174\/1568026617666170224122508","article-title":"Influenza A virus nucleoprotein: a highly conserved multi-functional viral protein as a hot antiviral drug target","volume":"17","author":"Hu","year":"2017","journal-title":"Curr topics medicinal Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-009-0064-x","article-title":"Structure and sequence analysis of influenza A virus nucleoprotein","volume":"52","author":"Ng","year":"2009","journal-title":"Sci China Ser C"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27662","article-title":"Evolutionary conservation and positive selection of influenza A nucleoprotein CTL epitopes for universal vaccination","volume":"94","author":"McGee","year":"2022","journal-title":"J Med virology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2015.06.030","article-title":"Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target","volume":"34","author":"Babar","year":"2015","journal-title":"Infection Genet Evolution"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001190","article-title":"Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets","volume":"2","author":"Heiny","year":"2007","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4161\/rna.29730","article-title":"RNA structural constraints in the evolution of the influenza A virus genome NP segment","volume":"11","author":"Gultyaev","year":"2014","journal-title":"RNA Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.202","article-title":"A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge","volume":"18","author":"Zhou","year":"2010","journal-title":"Mol Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-4-719","article-title":"Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes","volume":"67","author":"McMichael","year":"1986","journal-title":"J Gen virology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/498980","article-title":"Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature","volume":"193","author":"Epstein","year":"2006","journal-title":"J Infect diseases"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00151-9","article-title":"Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India","volume":"399","author":"Khobragade","year":"2022","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02894-y","article-title":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial","volume":"30","author":"Yarchoan","year":"2024","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(00)00170-1","article-title":"Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses","volume":"61","author":"Blazevic","year":"2000","journal-title":"Hum Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J Infect Diseases"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scandinavian J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10\u20131128","DOI":"10.1128\/JVI.01065-19","article-title":"A live attenuated influenza vaccine elicits enhanced heterologous protection when the internal genes of the vaccine are matched to those of the challenge virus","volume":"94","author":"Smith","year":"2020","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.02.036","article-title":"Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques","volume":"26","author":"Hirao","year":"2008","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0684.2005.00124.x","article-title":"SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques","volume":"34","author":"Boyer","year":"2005","journal-title":"J Med primatology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit236","article-title":"Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","volume":"208","author":"Kalams","year":"2013","journal-title":"J Infect diseases"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029231","article-title":"Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"Kalams","year":"2012","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003019","article-title":"Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors","volume":"9","author":"Vonderheide","year":"2021","journal-title":"J immunotherapy cancer"},{"key":"B38","unstructured":"World Health Organization\n          \n          2025"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA11: molecular evolutionary genetics analysis version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol Biol Evol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy537","article-title":"Protective efficacy and long-term immunogenicity in cynomolgus macaques by ebola virus glycoprotein synthetic DNA vaccines","volume":"219","author":"Patel","year":"2019","journal-title":"J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e10873","DOI":"10.1002\/ece3.10873","article-title":"TreeViewer: Flexible, modular software to visualise and manipulate phylogenetic trees","volume":"14","author":"Bianchini","year":"2024","journal-title":"Ecol Evol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102035","article-title":"Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity","volume":"102035","author":"Tursi","year":"2025","journal-title":"Cell Rep Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1998.18.537","article-title":"Coadministration of IL-12 or IL-10 expression cassettes drives immune responses toward a Th1 phenotype","volume":"18","author":"Kim","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnetjournal"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137079","article-title":"Robust antibody and cellular responses induced by DNA-only vaccination for HIV","volume":"5","author":"De Rosa","year":"2020","journal-title":"JCI Insight"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.5.2912","article-title":"IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge","volume":"162","author":"Sin","year":"1999","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.036","article-title":"Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice","volume":"22","author":"Chattergoon","year":"2004","journal-title":"Vaccine"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00867-24","article-title":"Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein","volume":"99","author":"Park","year":"2025","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/srep01443","article-title":"Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1","volume":"3","author":"Lambe","year":"2013","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"127231","DOI":"10.1016\/j.vaccine.2025.127231","article-title":"DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo","volume":"59","author":"Liaw","year":"2025","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.03.017","article-title":"Regulation of influenza A virus induced CXCL-10 gene expression requires PI3K\/Akt pathway and IRF3 transcription factor","volume":"48","author":"Lu","year":"2011","journal-title":"Mol Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666170316123736","article-title":"Cytokines induced during influenza virus infection","volume":"23","author":"Betakova","year":"2017","journal-title":"Curr Pharm design"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.3390\/v14112445","article-title":"CXCL10 chemokine: a critical player in RNA and DNA viral infections","volume":"14","author":"Elemam","year":"2022","journal-title":"Viruses"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj1120","article-title":"The chemokine receptor CXCR3 promotes CD8+ T cell\u2013dependent lung pathology during influenza pathogenesis","volume":"10","author":"Guo","year":"2024","journal-title":"Sci Adv"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2578","article-title":"Virus-induced host chemokine CCL2 in COVID-19 pathogenesis: potential prognostic marker and target of anti-inflammatory strategy","volume":"34","author":"Ansari","year":"2024","journal-title":"Rev Med Virology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4RU0820-232R","article-title":"From virus to inflammation, how influenza promotes lung damage","volume":"110","author":"Klomp","year":"2021","journal-title":"J Leukocyte Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J Infect diseases"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu186","article-title":"Association between antibody titers and protection against influenza virus infection within households","volume":"210","author":"Tsang","year":"2014","journal-title":"J Infect diseases"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1884","article-title":"Effect of antigenic drift on influenza vaccine effectiveness in the United States\u20142019\u20132020","volume":"73","author":"Tenforde","year":"2021","journal-title":"Clin Infect Diseases"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00297-16","article-title":"Neutralizing antibody responses to antigenically drifted influenza A (H3N2) viruses among children and adolescents following 2014\u20132015 inactivated and live attenuated influenza vaccination","volume":"23","author":"Levine","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.05.001","article-title":"Role of T cell immunity in recovery from influenza virus infection","volume":"3","author":"Sun","year":"2013","journal-title":"Curr Opin Virol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4049\/jimmunol.1200571","article-title":"Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection","volume":"190","author":"Hamada","year":"2013","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/82_2014_397","article-title":"The Effector T Cell Response to Influenza Infection. In: Oldstone, M., Compans, R. (eds)","volume":"386","author":"Hufford","year":"","journal-title":"Influenza Pathogenesis and Control - Volume II. Current Topics in Microbiology and Immunology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.959379","article-title":"The role of cell-mediated immunity against influenza and its implications for vaccine evaluation","volume":"13","author":"Janssens","year":"2022","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00611","article-title":"On the role of CD8(+) T cells in determining recovery time from influenza virus infection","volume":"7","author":"Cao","year":"2016","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00711-24","article-title":"The frequency and function of nucleoprotein-specific CD8(+) T cells are critical for heterosubtypic immunity against influenza virus infection","volume":"98","author":"Amoah","year":"2024","journal-title":"J Virol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4110\/in.2009.9.5.169","article-title":"Enhancement of DNA vaccine-induced immune responses by influenza virus NP gene","volume":"9","author":"Choi","year":"2009","journal-title":"Immune network"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.7.4163","article-title":"Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge","volume":"162","author":"Fu","year":"1999","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4161\/hv.3.5.4175","article-title":"Vaxfectin\u2122-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge","volume":"3","author":"Jimenez","year":"2007","journal-title":"Hum Vaccines"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161193","article-title":"Self-amplifying mRNA vaccines expressing multiple conserved influenza antigens confer protection against homologous and heterosubtypic viral challenge","volume":"11","author":"Magini","year":"2016","journal-title":"PLoS One"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.03.063","article-title":"Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates","volume":"40","author":"Flynn","year":"2022","journal-title":"Vaccine"},{"key":"B74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/vaccines12020157","article-title":"Development of NP-Based universal vaccine for Influenza A Viruses","volume":"12","author":"Sayedahmed","year":"2024","journal-title":"Vaccines"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242922","article-title":"Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+ M 1 coadministration with inactivated influenza vaccine","volume":"43","author":"Mullarkey","year":"2013","journal-title":"Eur J Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3390\/pathogens12070867","article-title":"Newly designed poxviral promoters to improve immunogenicity and efficacy of MVA-NP candidate vaccines against lethal influenza virus infection in mice","volume":"12","author":"Langenmayer","year":"2023","journal-title":"Pathogens"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00351-1","article-title":"Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"23","author":"Leroux-Roels","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678483","article-title":"OVX836 heptameric nucleoprotein vaccine generates lung tissue-resident memory CD8+ T-cells for cross-protection against influenza","volume":"12","author":"Del Campo","year":"2021","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.01.063","article-title":"Immunogenicity of novel consensus-based DNA vaccines against avian influenza","volume":"25","author":"Laddy","year":"2007","journal-title":"Vaccine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti\u2013spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Trans Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.010","article-title":"Synergy of immune checkpoint blockade with a novel synthetic consensus DNA vaccine targeting TERT","volume":"26","author":"Duperret","year":"2018","journal-title":"Mol Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.05.076","article-title":"Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine","volume":"29","author":"Yan","year":"2011","journal-title":"Vaccine"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01630","article-title":"Influenza vaccine with consensus internal antigens as immunogens provides cross-group protection against influenza A viruses","volume":"10","author":"Xie","year":"2019","journal-title":"Front Microbiol"},{"key":"B85","unstructured":"Process of Influenza Vaccine Virus Selection and Development"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.11.030","article-title":"Structure and sequence engineering approaches to improve in vivo expression of nucleic acid-delivered antibodies","volume":"33","author":"Helble","year":"2025","journal-title":"Mol Ther"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.celrep.2018.10.062","article-title":"In vivo delivery of synthetic human DNA-encoded monoclonal antibodies protect against ebolavirus infection in a mouse model","volume":"25","author":"Patel","year":"2018","journal-title":"Cell Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1632121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:32:01Z","timestamp":1764138721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1632121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2025.1632121"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1632121","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1632121"}}